Global Oral Vaccines Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.
Oral Vaccines segment by Company
1. To analyze and research the global Oral Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Vaccines industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.
Oral Vaccines segment by Company
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Oral Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Vaccines industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Vaccines Sales Value (2019-2030)
1.2.2 Global Oral Vaccines Sales Volume (2019-2030)
1.2.3 Global Oral Vaccines Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 ORAL VACCINES MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 ORAL VACCINES MARKET BY COMPANY
3.1 Global Oral Vaccines Company Revenue Ranking in 2023
3.2 Global Oral Vaccines Revenue by Company (2019-2024)
3.3 Global Oral Vaccines Sales Volume by Company (2019-2024)
3.4 Global Oral Vaccines Average Price by Company (2019-2024)
3.5 Global Oral Vaccines Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Oral Vaccines Company Manufacturing Base & Headquarters
3.7 Global Oral Vaccines Company, Product Type & Application
3.8 Global Oral Vaccines Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Oral Vaccines Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 ORAL VACCINES MARKET BY TYPE
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.2 Global Oral Vaccines Sales Volume by Type
4.2.1 Global Oral Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Oral Vaccines Sales Volume by Type (2019-2030)
4.2.3 Global Oral Vaccines Sales Volume Share by Type (2019-2030)
4.3 Global Oral Vaccines Sales Value by Type
4.3.1 Global Oral Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Oral Vaccines Sales Value by Type (2019-2030)
4.3.3 Global Oral Vaccines Sales Value Share by Type (2019-2030)
5 ORAL VACCINES MARKET BY APPLICATION
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales Volume by Application
5.2.1 Global Oral Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Oral Vaccines Sales Volume by Application (2019-2030)
5.2.3 Global Oral Vaccines Sales Volume Share by Application (2019-2030)
5.3 Global Oral Vaccines Sales Value by Application
5.3.1 Global Oral Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Oral Vaccines Sales Value by Application (2019-2030)
5.3.3 Global Oral Vaccines Sales Value Share by Application (2019-2030)
6 ORAL VACCINES MARKET BY REGION
6.1 Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Oral Vaccines Sales by Region (2019-2030)
6.2.1 Global Oral Vaccines Sales by Region: 2019-2024
6.2.2 Global Oral Vaccines Sales by Region (2025-2030)
6.3 Global Oral Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Oral Vaccines Sales Value by Region (2019-2030)
6.4.1 Global Oral Vaccines Sales Value by Region: 2019-2024
6.4.2 Global Oral Vaccines Sales Value by Region (2025-2030)
6.5 Global Oral Vaccines Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Oral Vaccines Sales Value (2019-2030)
6.6.2 North America Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Oral Vaccines Sales Value (2019-2030)
6.7.2 Europe Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Oral Vaccines Sales Value (2019-2030)
6.8.2 Asia-Pacific Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Oral Vaccines Sales Value (2019-2030)
6.9.2 Latin America Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Oral Vaccines Sales Value (2019-2030)
6.10.2 Middle East & Africa Oral Vaccines Sales Value Share by Country, 2023 VS 2030
7 ORAL VACCINES MARKET BY COUNTRY
7.1 Global Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Oral Vaccines Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Oral Vaccines Sales by Country (2019-2030)
7.3.1 Global Oral Vaccines Sales by Country (2019-2024)
7.3.2 Global Oral Vaccines Sales by Country (2025-2030)
7.4 Global Oral Vaccines Sales Value by Country (2019-2030)
7.4.1 Global Oral Vaccines Sales Value by Country (2019-2024)
7.4.2 Global Oral Vaccines Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.5.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.6.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.7.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.8.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.9.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.10.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.11.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.12.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.13.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.14.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.15.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.16.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.17.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.18.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.19.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.20.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.21.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.22.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.23.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck Oral Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Oral Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.3.4 Sanofi Oral Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Comapny Information
8.4.2 Lanzhou Institute Business Overview
8.4.3 Lanzhou Institute Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.4.5 Lanzhou Institute Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.5.4 Serum Institute Oral Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Valneva
8.6.1 Valneva Comapny Information
8.6.2 Valneva Business Overview
8.6.3 Valneva Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.6.4 Valneva Oral Vaccines Product Portfolio
8.6.5 Valneva Recent Developments
8.7 Shanghai United Cell
8.7.1 Shanghai United Cell Comapny Information
8.7.2 Shanghai United Cell Business Overview
8.7.3 Shanghai United Cell Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.7.5 Shanghai United Cell Recent Developments
8.8 Bibcol
8.8.1 Bibcol Comapny Information
8.8.2 Bibcol Business Overview
8.8.3 Bibcol Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.8.4 Bibcol Oral Vaccines Product Portfolio
8.8.5 Bibcol Recent Developments
8.9 PaxVax
8.9.1 PaxVax Comapny Information
8.9.2 PaxVax Business Overview
8.9.3 PaxVax Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.9.4 PaxVax Oral Vaccines Product Portfolio
8.9.5 PaxVax Recent Developments
8.10 Vabiotech
8.10.1 Vabiotech Comapny Information
8.10.2 Vabiotech Business Overview
8.10.3 Vabiotech Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.10.4 Vabiotech Oral Vaccines Product Portfolio
8.10.5 Vabiotech Recent Developments
8.11 Tiantan Biological
8.11.1 Tiantan Biological Comapny Information
8.11.2 Tiantan Biological Business Overview
8.11.3 Tiantan Biological Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
8.11.5 Tiantan Biological Recent Developments
8.12 EuBiologics
8.12.1 EuBiologics Comapny Information
8.12.2 EuBiologics Business Overview
8.12.3 EuBiologics Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.12.4 EuBiologics Oral Vaccines Product Portfolio
8.12.5 EuBiologics Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Comapny Information
8.13.2 Panacea Biotec Ltd Business Overview
8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 Bio-Med
8.14.1 Bio-Med Comapny Information
8.14.2 Bio-Med Business Overview
8.14.3 Bio-Med Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.14.4 Bio-Med Oral Vaccines Product Portfolio
8.14.5 Bio-Med Recent Developments
8.15 Halfkin Bio-Pharmaceuticals
8.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Sales Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Vaccines Sales Value (2019-2030)
1.2.2 Global Oral Vaccines Sales Volume (2019-2030)
1.2.3 Global Oral Vaccines Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 ORAL VACCINES MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 ORAL VACCINES MARKET BY COMPANY
3.1 Global Oral Vaccines Company Revenue Ranking in 2023
3.2 Global Oral Vaccines Revenue by Company (2019-2024)
3.3 Global Oral Vaccines Sales Volume by Company (2019-2024)
3.4 Global Oral Vaccines Average Price by Company (2019-2024)
3.5 Global Oral Vaccines Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Oral Vaccines Company Manufacturing Base & Headquarters
3.7 Global Oral Vaccines Company, Product Type & Application
3.8 Global Oral Vaccines Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Oral Vaccines Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 ORAL VACCINES MARKET BY TYPE
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.2 Global Oral Vaccines Sales Volume by Type
4.2.1 Global Oral Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Oral Vaccines Sales Volume by Type (2019-2030)
4.2.3 Global Oral Vaccines Sales Volume Share by Type (2019-2030)
4.3 Global Oral Vaccines Sales Value by Type
4.3.1 Global Oral Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Oral Vaccines Sales Value by Type (2019-2030)
4.3.3 Global Oral Vaccines Sales Value Share by Type (2019-2030)
5 ORAL VACCINES MARKET BY APPLICATION
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales Volume by Application
5.2.1 Global Oral Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Oral Vaccines Sales Volume by Application (2019-2030)
5.2.3 Global Oral Vaccines Sales Volume Share by Application (2019-2030)
5.3 Global Oral Vaccines Sales Value by Application
5.3.1 Global Oral Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Oral Vaccines Sales Value by Application (2019-2030)
5.3.3 Global Oral Vaccines Sales Value Share by Application (2019-2030)
6 ORAL VACCINES MARKET BY REGION
6.1 Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Oral Vaccines Sales by Region (2019-2030)
6.2.1 Global Oral Vaccines Sales by Region: 2019-2024
6.2.2 Global Oral Vaccines Sales by Region (2025-2030)
6.3 Global Oral Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Oral Vaccines Sales Value by Region (2019-2030)
6.4.1 Global Oral Vaccines Sales Value by Region: 2019-2024
6.4.2 Global Oral Vaccines Sales Value by Region (2025-2030)
6.5 Global Oral Vaccines Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Oral Vaccines Sales Value (2019-2030)
6.6.2 North America Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Oral Vaccines Sales Value (2019-2030)
6.7.2 Europe Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Oral Vaccines Sales Value (2019-2030)
6.8.2 Asia-Pacific Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Oral Vaccines Sales Value (2019-2030)
6.9.2 Latin America Oral Vaccines Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Oral Vaccines Sales Value (2019-2030)
6.10.2 Middle East & Africa Oral Vaccines Sales Value Share by Country, 2023 VS 2030
7 ORAL VACCINES MARKET BY COUNTRY
7.1 Global Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Oral Vaccines Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Oral Vaccines Sales by Country (2019-2030)
7.3.1 Global Oral Vaccines Sales by Country (2019-2024)
7.3.2 Global Oral Vaccines Sales by Country (2025-2030)
7.4 Global Oral Vaccines Sales Value by Country (2019-2030)
7.4.1 Global Oral Vaccines Sales Value by Country (2019-2024)
7.4.2 Global Oral Vaccines Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.5.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.6.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.7.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.8.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.9.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.10.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.11.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.12.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.13.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.14.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.15.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.16.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.17.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.18.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.19.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.20.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.21.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.22.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Oral Vaccines Sales Value Growth Rate (2019-2030)
7.23.2 Global Oral Vaccines Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Oral Vaccines Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.1.4 Merck Oral Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Oral Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.3.4 Sanofi Oral Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Comapny Information
8.4.2 Lanzhou Institute Business Overview
8.4.3 Lanzhou Institute Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.4.5 Lanzhou Institute Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.5.4 Serum Institute Oral Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Valneva
8.6.1 Valneva Comapny Information
8.6.2 Valneva Business Overview
8.6.3 Valneva Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.6.4 Valneva Oral Vaccines Product Portfolio
8.6.5 Valneva Recent Developments
8.7 Shanghai United Cell
8.7.1 Shanghai United Cell Comapny Information
8.7.2 Shanghai United Cell Business Overview
8.7.3 Shanghai United Cell Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.7.5 Shanghai United Cell Recent Developments
8.8 Bibcol
8.8.1 Bibcol Comapny Information
8.8.2 Bibcol Business Overview
8.8.3 Bibcol Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.8.4 Bibcol Oral Vaccines Product Portfolio
8.8.5 Bibcol Recent Developments
8.9 PaxVax
8.9.1 PaxVax Comapny Information
8.9.2 PaxVax Business Overview
8.9.3 PaxVax Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.9.4 PaxVax Oral Vaccines Product Portfolio
8.9.5 PaxVax Recent Developments
8.10 Vabiotech
8.10.1 Vabiotech Comapny Information
8.10.2 Vabiotech Business Overview
8.10.3 Vabiotech Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.10.4 Vabiotech Oral Vaccines Product Portfolio
8.10.5 Vabiotech Recent Developments
8.11 Tiantan Biological
8.11.1 Tiantan Biological Comapny Information
8.11.2 Tiantan Biological Business Overview
8.11.3 Tiantan Biological Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
8.11.5 Tiantan Biological Recent Developments
8.12 EuBiologics
8.12.1 EuBiologics Comapny Information
8.12.2 EuBiologics Business Overview
8.12.3 EuBiologics Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.12.4 EuBiologics Oral Vaccines Product Portfolio
8.12.5 EuBiologics Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Comapny Information
8.13.2 Panacea Biotec Ltd Business Overview
8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 Bio-Med
8.14.1 Bio-Med Comapny Information
8.14.2 Bio-Med Business Overview
8.14.3 Bio-Med Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.14.4 Bio-Med Oral Vaccines Product Portfolio
8.14.5 Bio-Med Recent Developments
8.15 Halfkin Bio-Pharmaceuticals
8.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Value and Gross Margin (2019-2024)
8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Sales Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Oral Vaccines Industry Trends
Table 2. Oral Vaccines Industry Drivers
Table 3. Oral Vaccines Industry Opportunities and Challenges
Table 4. Oral Vaccines Industry Restraints
Table 5. Global Oral Vaccines Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Oral Vaccines Revenue Share by Company (2019-2024)
Table 7. Global Oral Vaccines Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Oral Vaccines Sales Volume Share by Company (2019-2024)
Table 9. Global Oral Vaccines Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Oral Vaccines Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Oral Vaccines Key Company Manufacturing Base & Headquarters
Table 12. Global Oral Vaccines Company, Product Type & Application
Table 13. Global Oral Vaccines Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Rotavirus Vaccine
Table 18. Major Companies of Cholera Vaccine
Table 19. Major Companies of Oral Polio Vaccine
Table 20. Global Oral Vaccines Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Oral Vaccines Sales Volume by Type (2019-2024) & (M Doses)
Table 22. Global Oral Vaccines Sales Volume by Type (2025-2030) & (M Doses)
Table 23. Global Oral Vaccines Sales Volume Share by Type (2019-2024)
Table 24. Global Oral Vaccines Sales Volume Share by Type (2025-2030)
Table 25. Global Oral Vaccines Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Oral Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Oral Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Oral Vaccines Sales Value Share by Type (2019-2024)
Table 29. Global Oral Vaccines Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Public
Table 31. Major Companies of Private
Table 32. Global Oral Vaccines Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 33. Global Oral Vaccines Sales Volume by Application (2019-2024) & (M Doses)
Table 34. Global Oral Vaccines Sales Volume by Application (2025-2030) & (M Doses)
Table 35. Global Oral Vaccines Sales Volume Share by Application (2019-2024)
Table 36. Global Oral Vaccines Sales Volume Share by Application (2025-2030)
Table 37. Global Oral Vaccines Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Oral Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Oral Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Oral Vaccines Sales Value Share by Application (2019-2024)
Table 41. Global Oral Vaccines Sales Value Share by Application (2025-2030)
Table 42. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 43. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 44. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 45. Global Oral Vaccines Sales by Region (2025-2030) & (M Doses)
Table 46. Global Oral Vaccines Sales Market Share by Region (2025-2030)
Table 47. Global Oral Vaccines Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Oral Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Oral Vaccines Sales Value Share by Region (2019-2024)
Table 50. Global Oral Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Oral Vaccines Sales Value Share by Region (2025-2030)
Table 52. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2019-2024)
Table 53. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2025-2030)
Table 54. Global Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. Global Oral Vaccines Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 57. Global Oral Vaccines Sales Market Share by Country (2019-2024)
Table 58. Global Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 59. Global Oral Vaccines Sales Market Share by Country (2025-2030)
Table 60. Global Oral Vaccines Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Oral Vaccines Sales Value Market Share by Country (2019-2024)
Table 62. Global Oral Vaccines Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Oral Vaccines Sales Value Market Share by Country (2025-2030)
Table 64. Merck Company Information
Table 65. Merck Business Overview
Table 66. Merck Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 67. Merck Oral Vaccines Product Portfolio
Table 68. Merck Recent Development
Table 69. GSK Company Information
Table 70. GSK Business Overview
Table 71. GSK Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 72. GSK Oral Vaccines Product Portfolio
Table 73. GSK Recent Development
Table 74. Sanofi Company Information
Table 75. Sanofi Business Overview
Table 76. Sanofi Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 77. Sanofi Oral Vaccines Product Portfolio
Table 78. Sanofi Recent Development
Table 79. Lanzhou Institute Company Information
Table 80. Lanzhou Institute Business Overview
Table 81. Lanzhou Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Lanzhou Institute Oral Vaccines Product Portfolio
Table 83. Lanzhou Institute Recent Development
Table 84. Serum Institute Company Information
Table 85. Serum Institute Business Overview
Table 86. Serum Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Serum Institute Oral Vaccines Product Portfolio
Table 88. Serum Institute Recent Development
Table 89. Valneva Company Information
Table 90. Valneva Business Overview
Table 91. Valneva Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Valneva Oral Vaccines Product Portfolio
Table 93. Valneva Recent Development
Table 94. Shanghai United Cell Company Information
Table 95. Shanghai United Cell Business Overview
Table 96. Shanghai United Cell Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Shanghai United Cell Oral Vaccines Product Portfolio
Table 98. Shanghai United Cell Recent Development
Table 99. Bibcol Company Information
Table 100. Bibcol Business Overview
Table 101. Bibcol Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. Bibcol Oral Vaccines Product Portfolio
Table 103. Bibcol Recent Development
Table 104. PaxVax Company Information
Table 105. PaxVax Business Overview
Table 106. PaxVax Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. PaxVax Oral Vaccines Product Portfolio
Table 108. PaxVax Recent Development
Table 109. Vabiotech Company Information
Table 110. Vabiotech Business Overview
Table 111. Vabiotech Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. Vabiotech Oral Vaccines Product Portfolio
Table 113. Vabiotech Recent Development
Table 114. Tiantan Biological Company Information
Table 115. Tiantan Biological Business Overview
Table 116. Tiantan Biological Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Tiantan Biological Oral Vaccines Product Portfolio
Table 118. Tiantan Biological Recent Development
Table 119. EuBiologics Company Information
Table 120. EuBiologics Business Overview
Table 121. EuBiologics Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. EuBiologics Oral Vaccines Product Portfolio
Table 123. EuBiologics Recent Development
Table 124. Panacea Biotec Ltd Company Information
Table 125. Panacea Biotec Ltd Business Overview
Table 126. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 128. Panacea Biotec Ltd Recent Development
Table 129. Bio-Med Company Information
Table 130. Bio-Med Business Overview
Table 131. Bio-Med Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Bio-Med Oral Vaccines Product Portfolio
Table 133. Bio-Med Recent Development
Table 134. Halfkin Bio-Pharmaceuticals Company Information
Table 135. Halfkin Bio-Pharmaceuticals Business Overview
Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 137. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 138. Halfkin Bio-Pharmaceuticals Recent Development
Table 139. Key Raw Materials
Table 140. Raw Materials Key Suppliers
Table 141. Oral Vaccines Distributors List
Table 142. Oral Vaccines Customers List
Table 143. Research Programs/Design for This Report
Table 144. Authors List of This Report
Table 145. Secondary Sources
Table 146. Primary Sources
Table 1. Oral Vaccines Industry Trends
Table 2. Oral Vaccines Industry Drivers
Table 3. Oral Vaccines Industry Opportunities and Challenges
Table 4. Oral Vaccines Industry Restraints
Table 5. Global Oral Vaccines Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Oral Vaccines Revenue Share by Company (2019-2024)
Table 7. Global Oral Vaccines Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Oral Vaccines Sales Volume Share by Company (2019-2024)
Table 9. Global Oral Vaccines Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Oral Vaccines Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Oral Vaccines Key Company Manufacturing Base & Headquarters
Table 12. Global Oral Vaccines Company, Product Type & Application
Table 13. Global Oral Vaccines Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Rotavirus Vaccine
Table 18. Major Companies of Cholera Vaccine
Table 19. Major Companies of Oral Polio Vaccine
Table 20. Global Oral Vaccines Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Oral Vaccines Sales Volume by Type (2019-2024) & (M Doses)
Table 22. Global Oral Vaccines Sales Volume by Type (2025-2030) & (M Doses)
Table 23. Global Oral Vaccines Sales Volume Share by Type (2019-2024)
Table 24. Global Oral Vaccines Sales Volume Share by Type (2025-2030)
Table 25. Global Oral Vaccines Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Oral Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Oral Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Oral Vaccines Sales Value Share by Type (2019-2024)
Table 29. Global Oral Vaccines Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Public
Table 31. Major Companies of Private
Table 32. Global Oral Vaccines Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 33. Global Oral Vaccines Sales Volume by Application (2019-2024) & (M Doses)
Table 34. Global Oral Vaccines Sales Volume by Application (2025-2030) & (M Doses)
Table 35. Global Oral Vaccines Sales Volume Share by Application (2019-2024)
Table 36. Global Oral Vaccines Sales Volume Share by Application (2025-2030)
Table 37. Global Oral Vaccines Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Oral Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Oral Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Oral Vaccines Sales Value Share by Application (2019-2024)
Table 41. Global Oral Vaccines Sales Value Share by Application (2025-2030)
Table 42. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 43. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 44. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 45. Global Oral Vaccines Sales by Region (2025-2030) & (M Doses)
Table 46. Global Oral Vaccines Sales Market Share by Region (2025-2030)
Table 47. Global Oral Vaccines Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Oral Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Oral Vaccines Sales Value Share by Region (2019-2024)
Table 50. Global Oral Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Oral Vaccines Sales Value Share by Region (2025-2030)
Table 52. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2019-2024)
Table 53. Global Oral Vaccines Market Average Price (USD/K Doses) by Region (2025-2030)
Table 54. Global Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. Global Oral Vaccines Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 57. Global Oral Vaccines Sales Market Share by Country (2019-2024)
Table 58. Global Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 59. Global Oral Vaccines Sales Market Share by Country (2025-2030)
Table 60. Global Oral Vaccines Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Oral Vaccines Sales Value Market Share by Country (2019-2024)
Table 62. Global Oral Vaccines Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Oral Vaccines Sales Value Market Share by Country (2025-2030)
Table 64. Merck Company Information
Table 65. Merck Business Overview
Table 66. Merck Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 67. Merck Oral Vaccines Product Portfolio
Table 68. Merck Recent Development
Table 69. GSK Company Information
Table 70. GSK Business Overview
Table 71. GSK Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 72. GSK Oral Vaccines Product Portfolio
Table 73. GSK Recent Development
Table 74. Sanofi Company Information
Table 75. Sanofi Business Overview
Table 76. Sanofi Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 77. Sanofi Oral Vaccines Product Portfolio
Table 78. Sanofi Recent Development
Table 79. Lanzhou Institute Company Information
Table 80. Lanzhou Institute Business Overview
Table 81. Lanzhou Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Lanzhou Institute Oral Vaccines Product Portfolio
Table 83. Lanzhou Institute Recent Development
Table 84. Serum Institute Company Information
Table 85. Serum Institute Business Overview
Table 86. Serum Institute Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Serum Institute Oral Vaccines Product Portfolio
Table 88. Serum Institute Recent Development
Table 89. Valneva Company Information
Table 90. Valneva Business Overview
Table 91. Valneva Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Valneva Oral Vaccines Product Portfolio
Table 93. Valneva Recent Development
Table 94. Shanghai United Cell Company Information
Table 95. Shanghai United Cell Business Overview
Table 96. Shanghai United Cell Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Shanghai United Cell Oral Vaccines Product Portfolio
Table 98. Shanghai United Cell Recent Development
Table 99. Bibcol Company Information
Table 100. Bibcol Business Overview
Table 101. Bibcol Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. Bibcol Oral Vaccines Product Portfolio
Table 103. Bibcol Recent Development
Table 104. PaxVax Company Information
Table 105. PaxVax Business Overview
Table 106. PaxVax Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. PaxVax Oral Vaccines Product Portfolio
Table 108. PaxVax Recent Development
Table 109. Vabiotech Company Information
Table 110. Vabiotech Business Overview
Table 111. Vabiotech Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. Vabiotech Oral Vaccines Product Portfolio
Table 113. Vabiotech Recent Development
Table 114. Tiantan Biological Company Information
Table 115. Tiantan Biological Business Overview
Table 116. Tiantan Biological Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Tiantan Biological Oral Vaccines Product Portfolio
Table 118. Tiantan Biological Recent Development
Table 119. EuBiologics Company Information
Table 120. EuBiologics Business Overview
Table 121. EuBiologics Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. EuBiologics Oral Vaccines Product Portfolio
Table 123. EuBiologics Recent Development
Table 124. Panacea Biotec Ltd Company Information
Table 125. Panacea Biotec Ltd Business Overview
Table 126. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 128. Panacea Biotec Ltd Recent Development
Table 129. Bio-Med Company Information
Table 130. Bio-Med Business Overview
Table 131. Bio-Med Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Bio-Med Oral Vaccines Product Portfolio
Table 133. Bio-Med Recent Development
Table 134. Halfkin Bio-Pharmaceuticals Company Information
Table 135. Halfkin Bio-Pharmaceuticals Business Overview
Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 137. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 138. Halfkin Bio-Pharmaceuticals Recent Development
Table 139. Key Raw Materials
Table 140. Raw Materials Key Suppliers
Table 141. Oral Vaccines Distributors List
Table 142. Oral Vaccines Customers List
Table 143. Research Programs/Design for This Report
Table 144. Authors List of This Report
Table 145. Secondary Sources
Table 146. Primary Sources
LIST OF FIGURES
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Global Oral Vaccines Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Oral Vaccines Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Rotavirus Vaccine Picture
Figure 10. Cholera Vaccine Picture
Figure 11. Oral Polio Vaccine Picture
Figure 12. Global Oral Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 13. Global Oral Vaccines Sales Volume Share 2019 VS 2023 VS 2030
Figure 14. Global Oral Vaccines Sales Volume Share by Type (2019-2030)
Figure 15. Global Oral Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Oral Vaccines Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Oral Vaccines Sales Value Share by Type (2019-2030)
Figure 18. Public Picture
Figure 19. Private Picture
Figure 20. Global Oral Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 21. Global Oral Vaccines Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Oral Vaccines Sales Volume Share by Application (2019-2030)
Figure 23. Global Oral Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Oral Vaccines Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Oral Vaccines Sales Value Share by Application (2019-2030)
Figure 26. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 27. Global Oral Vaccines Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Oral Vaccines Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Oral Vaccines Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Global Oral Vaccines Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Oral Vaccines Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Rotavirus Vaccine Picture
Figure 10. Cholera Vaccine Picture
Figure 11. Oral Polio Vaccine Picture
Figure 12. Global Oral Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 13. Global Oral Vaccines Sales Volume Share 2019 VS 2023 VS 2030
Figure 14. Global Oral Vaccines Sales Volume Share by Type (2019-2030)
Figure 15. Global Oral Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Oral Vaccines Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Oral Vaccines Sales Value Share by Type (2019-2030)
Figure 18. Public Picture
Figure 19. Private Picture
Figure 20. Global Oral Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 21. Global Oral Vaccines Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Oral Vaccines Sales Volume Share by Application (2019-2030)
Figure 23. Global Oral Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Oral Vaccines Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Oral Vaccines Sales Value Share by Application (2019-2030)
Figure 26. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 27. Global Oral Vaccines Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Oral Vaccines Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Oral Vaccines Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Oral Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Oral Vaccines Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey Oral Vaccines Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey Oral Vaccines Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia Oral Vaccines Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi
